Shelby D. Reed, PhD, RPh is Professor in Population Health Sciences and Medicine at Duke University, Faculty Leader of the Center for Informing Health Decisions, and Director of the Preference Evaluation Research (PrefER) Group at the Duke Clinical Research Institute. She also is core faculty and serves on the executive committee at the Duke-Margolis Center for Health Policy. Dr. Reed has over 20 years of experience leading multidisciplinary health outcomes research studies. Dr. Reed has extensive expertise in designing and conducting trial-based and model-based cost-effectiveness analyses of diagnostics, drugs and patient-centered interventions. Her research currently focuses on stated-preference studies to evaluate benefit-risk tradeoffs and their application in comparative effectiveness research, clinical decision making and value frameworks.
In 2016, she co-founded the Preference Evaluation Research (PrefER) Group at the DCRI with Dr. Reed Johnson, and she currently serves as its director. She and the group are frequently sought to conduct stated-preference studies to inform regulatory decisions, health policy, care delivery, value assessment and clinical decision making with applied projects spanning a wide range of therapeutic areas, including cardiology, cancer, autoimmune disorders, orthopedic surgery, endocrine, and neurology.
She served as President for ISPOR in 2017-2018, and she currently is Chair of the Society’s Health Science Policy Council.